Investing.com - Tasly Pharm reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Tasly Pharm announced earnings per share of ¥0.05 on revenue of ¥2.09. Analysts polled by Investing.com anticipated EPS of ¥0.16 on revenue of ¥6.86B.
Tasly Pharm shares are up 78% from the beginning of the year, still down 38.98% from its 52 week high of ¥17.24 set on January 4.
Tasly Pharm shares gained 3.65% in intra-day trade following the report.
Tasly Pharm follows other major Healthcare sector earnings this month
Tasly Pharm's report follows an earnings missed by Aier Eye Hospital Group on Wednesday, who reported EPS of ¥0.15 on revenue of ¥4.94B, compared to forecasts EPS of ¥0.1722 on revenue of ¥5.7B.
Imeik had missed expectations on Wednesday with third quarter EPS of ¥1.85 on revenue of ¥604.5M, compared to forecast for EPS of ¥1.95 on revenue of ¥692.11M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar